[Federal Register Volume 69, Number 159 (Friday, October 8, 2004)]
[Notices]
[Page 60409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-22662]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Special Grants Review Committee Review of Research
Scientist Development Award--Research & Training (KO1), Research
Scientist Development Award--Research (K02), Clinical Investigator
Award--CIA (K08), Conference (R13), & Institutional National
Research Service Award (T32).
Date: October 14-15, 2004.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Yan Z. Wang, BA, PhD., Scientific Review
Administrator, National Institute of Arthritis and Musculoskeletal
and Skin Diseases, 6701 Democracy Blvd., Suite 820, Bethesda, MD
20892, (301) 594-4957, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: September 30, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-22662 Filed 10-7-04; 8:45 am]
BILLING CODE 4140-01-M